News
FDA issued draft guidance on Bioanalytical Method Validation
The draft guideline published by the FDA defines the criteria that have to be fulfilled by analytical methods used for the assessment of drug compounds and their metabolites and of biomarkers. The most important changes – especially the clear requirements to validate methods used for biomarkers – have been summarised in the paper published in European Biotechnology News which camn be downloaded here.
